HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Equities researchers at HC Wainwright issued their Q1 2028 earnings estimates for shares of HIVE Blockchain Technologies in a research report issued to clients and investors on Monday, August 17th. HC Wainwright analyst M. Colonnese forecasts that the company will post earnings per share of ($0.07) for the quarter. HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q2 2028 earnings at ($0.07) EPS, Q3 2028 earnings at ($0.08) EPS and Q4 2028 earnings at ($0.10) EPS.
Separately, Chardan Capital upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Monday, July 27th. Two equities research analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy”.
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a technology company in the Application Software industry.
Featured Stories
- Five stocks we like better than HIVE Blockchain Technologies
- Moonshot to Money: Intuitive Machines Lands $600M Defense Win
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
